Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: TIS for Brain Network Modulation and Clinical Efficacy in Parkinson's Disease [NA]
Clinical trial update on Transcranial Interference Stimulation (TIS) for brain network modulation in Parkinson's disease; the study is not y…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease [Phase 2]
Ongoing Phase 2 clinical trial evaluating probiotic treatment for depression and associated mood disorders in Parkinson disease; the study i…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: In Vivo Measurement of the Accuracy of the "Neurolocate" Module of the Neurosurgical Robot "Neuromate" in Its Application to Deep Brain Stimulation
A completed clinical trial evaluated the in vivo accuracy of the Neurolocate module of the Neuromate neurosurgical robot for deep brain stim…
-
CLINICAL_TRIALS withdrawal · 2026-03-24Clinical Trial Update: Context- and Terrain-aware Gait Analysis
A University of Leeds clinical trial evaluating context- and terrain-aware gait analysis in Parkinson's disease, dementia, and related condi…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Respiratory Functions in Parkinson's Disease
This clinical trial update indicates a study on respiratory functions in Parkinson disease sponsored by Ankara University is currently recru…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Brain Activity, Cognitive Function, and Walking Ability in Parkinson's Disease
This clinical trial is studying brain activity, cognitive function, and walking ability in people with Parkinson's disease. It is currently …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Early Parkinson's Disease Monotherapy With CVN424 [Phase 2]
Phase 2 trial of CVN424 as monotherapy for early Parkinson's disease has completed and results have been posted.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life
This clinical trial investigates the feasibility and potential benefits of continuous subcutaneous apomorphine in Parkinson's disease patien…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Effects of the Stimulation Site of tsMS With TMS on Functional Mobility in Individuals With Parkinson's Disease [NA]
This clinical trial update describes a study examining the effects of stimulation site for tsMS with TMS on functional mobility in individua…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome [NA]
A completed clinical trial evaluating ketogenic diet interventions in Parkinson's disease with a focus on safeguarding the gut microbiome.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Microbiome and Diet in Parkinson's Disease [NA]
This entry notes an ongoing clinical trial from the University of British Columbia studying the relationship between the gut microbiome, die…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's Disease Patients [NA]
A clinical trial is investigating targeted temporal interference stimulation of cerebellar nuclei to address tremor and gait disturbance in …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease. [Phase 4]
A Phase 4 clinical study evaluating dihydroergotine mesylate extended-release tablets for reducing drooling in Parkinson's disease has compl…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis
This Acibadem University clinical trial investigates determinants of physical frailty in Parkinson disease and is currently not recruiting. …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Targeting Apathy With Music in Parkinson's Disease [NA]
Recruitment is ongoing for a study evaluating a music-based intervention to target apathy in Parkinson disease.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease
A Turkish version of the Cognitive Self-Efficacy Questionnaire is being studied for use in people with Parkinson's disease; the trial is cur…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: "Self-Compassion and Self-Efficacy in Parkinson's Disease: Associations With Symptoms, Function, and Quality of Life"
A clinical trial update from Acibadem University examining how self-compassion and self-efficacy relate to Parkinson disease symptoms, funct…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Cue X as a Treatment for People With Parkinson's Disease [NA]
The document reports a completed clinical trial evaluating Cue X as a treatment for Parkinson's disease.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease [Phase 4]
Phase 4 clinical trial evaluating the effects of lemborexant on motor-sleep comorbidity in Parkinson's disease; the study is currently recru…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease [NA]
A clinical trial evaluating blood-brain barrier disruption using Cerezyme (imiglucerase) in Parkinson disease has completed.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
This document describes a post-approval registry for Exablate 4000 Type 1.0/1.1 unilateral thalamotomy, evaluating its use for tremor in tre…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: LFP-based Parameter Prediction in DBS for Parkinson's Disease
This clinical trial update describes a study investigating local field potential-based parameter prediction in deep brain stimulation for Pa…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PD [NA]
A completed feasibility study evaluating the safety and preliminary efficacy of bilateral subthalamotomy using MR-guided focused ultrasound …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease [NA]
Clinical trial update on ExAblate Pallidotomy for medically refractory dyskinesia or motor fluctuations in advanced Parkinson disease; the s…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers [NA]
A clinical trial to test dyadic mindfulness for people with Parkinson's disease and their caregivers. The study is currently recruiting.